Estimation of failure probabilities in the presence of competing risks: new representations of old estimators - PubMed

Review

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

T A Gooley et al. Stat Med. 1999.

Abstract

A topic that has received attention in both the statistical and medical literature is the estimation of the probability of failure for endpoints that are subject to competing risks. Despite this, it is not uncommon to see the complement of the Kaplan-Meier estimate used in this setting and interpreted as the probability of failure. If one desires an estimate that can be interpreted in this way, however, the cumulative incidence estimate is the appropriate tool to use in such situations. We believe the more commonly seen representations of the Kaplan-Meier estimate and the cumulative incidence estimate do not lend themselves to easy explanation and understanding of this interpretation. We present, therefore, a representation of each estimate in a manner not ordinarily seen, each representation utilizing the concept of censored observations being 'redistributed to the right.' We feel these allow a more intuitive understanding of each estimate and therefore an appreciation of why the Kaplan-Meier method is inappropriate for estimation purposes in the presence of competing risks, while the cumulative incidence estimate is appropriate.

Similar articles

• A note on competing risks in survival data analysis.

  Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. Satagopan JM, et al. Br J Cancer. 2004 Oct 4;91(7):1229-35. doi: 10.1038/sj.bjc.6602102. Br J Cancer. 2004. PMID: 15305188 Free PMC article. Review.

• Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.

  Lacny S, Wilson T, Clement F, Roberts DJ, Faris PD, Ghali WA, Marshall DA. Lacny S, et al. Clin Orthop Relat Res. 2015 Nov;473(11):3431-42. doi: 10.1007/s11999-015-4235-8. Clin Orthop Relat Res. 2015. PMID: 25804881 Free PMC article. Review.

• Overestimation of prostate cancer mortality and other-cause mortality by the Kaplan-Meier method.

  Zhu X, Kranse R, Bul M, Bangma CH, Schröder FH, Roobol MJ. Zhu X, et al. Can J Urol. 2013 Jun;20(3):6756-60. Can J Urol. 2013. PMID: 23783043

• Actual and actuarial probabilities of competing risks: apples and lemons.

  Grunkemeier GL, Jin R, Eijkemans MJ, Takkenberg JJ. Grunkemeier GL, et al. Ann Thorac Surg. 2007 May;83(5):1586-92. doi: 10.1016/j.athoracsur.2006.11.044. Ann Thorac Surg. 2007. PMID: 17462363

• Cumulative incidence in competing risks data and competing risks regression analysis.

  Kim HT. Kim HT. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):559-65. doi: 10.1158/1078-0432.CCR-06-1210. Clin Cancer Res. 2007. PMID: 17255278

Cited by

• Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.

  Lengfelder E, Lo-Coco F, Ades L, Montesinos P, Grimwade D, Kishore B, Ramadan SM, Pagoni M, Breccia M, Huerta AJ, Nloga AM, González-Sanmiguel JD, Schmidt A, Lambert JF, Lehmann S, Di Bona E, Cassinat B, Hofmann WK, Görlich D, Sauerland MC, Fenaux P, Sanz M; European LeukemiaNet. Lengfelder E, et al. Leukemia. 2015 May;29(5):1084-91. doi: 10.1038/leu.2015.12. Epub 2015 Jan 28. Leukemia. 2015. PMID: 25627637

• Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study.

  Parpia S, Thabane L, Julian JA, Whelan TJ, Levine MN. Parpia S, et al. BMC Med Res Methodol. 2013 Mar 21;13:44. doi: 10.1186/1471-2288-13-44. BMC Med Res Methodol. 2013. PMID: 23517401 Free PMC article.

• Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.

  Lengfelder E, Hanfstein B, Haferlach C, Braess J, Krug U, Spiekermann K, Haferlach T, Kreuzer KA, Serve H, Horst HA, Schnittger S, Aul C, Schultheis B, Erben P, Schneider S, Müller-Tidow C, Wörmann B, Berdel WE, Sauerland C, Heinecke A, Hehlmann R, Hofmann WK, Hiddemann W, Büchner T; German Acute Myeloid Leukemia Cooperative Group (AMLCG). Lengfelder E, et al. Ann Hematol. 2013 Jan;92(1):41-52. doi: 10.1007/s00277-012-1597-9. Epub 2012 Oct 23. Ann Hematol. 2013. PMID: 23090499 Free PMC article.

• Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.

  Khan R, Apewokin S, Grazziutti M, Yaccoby S, Epstein J, van Rhee F, Rosenthal A, Waheed S, Usmani S, Atrash S, Kumar S, Hoering A, Crowley J, Shaughnessy JD Jr, Barlogie B. Khan R, et al. Leukemia. 2015 May;29(5):1195-201. doi: 10.1038/leu.2015.15. Epub 2012 Feb 2. Leukemia. 2015. PMID: 25640885 Free PMC article.

• Association of platinum-based chemotherapy with live birth and infertility in female survivors of adolescent and young adult cancer.

  Zhou B, Kwan B, Desai MJ, Nalawade V, Henk J, Viravalli N, Murphy JD, Nathan PC, Ruddy KJ, Shliakhtsitsava K, Su HI, Whitcomb BW. Zhou B, et al. Fertil Steril. 2024 Jun;121(6):1020-1030. doi: 10.1016/j.fertnstert.2024.01.039. Epub 2024 Feb 3. Fertil Steril. 2024. PMID: 38316209

Publication types

MeSH terms

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database